apparent diffusion coefficient adc value (Bruker Corporation)
Bruker Corporation is a verified supplier 
97
Structured Review
Bruker Corporation
apparent diffusion coefficient adc value
Apparent Diffusion Coefficient Adc Value, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 97/100, based on 3073 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apparent+diffusion+coefficient+adc+value/Diffusion/pm35152130-66-11-29
Average 97 stars, based on 3073 article reviews
Apparent Diffusion Coefficient Adc Value, supplied by Bruker Corporation, used in various techniques. Bioz Stars score: 97/100, based on 3073 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apparent+diffusion+coefficient+adc+value/Diffusion/pm35152130-66-11-29
Average 97 stars, based on 3073 article reviews
apparent diffusion coefficient adc value - by Bioz Stars,
2026-09
97/100 stars
Images
Related Articles
Diffusion-based Assay:Article Title: Tideglusib Ameliorates Ischemia/Reperfusion Damage by Inhibiting GSK-3β and Apoptosis in Rat Model of Ischemic Stroke. Article Snippet: rnal of Stroke and Cer Objectives: Glycogen synthase kinase-3b (GSK-3b), a serine/threonine protein kinase, gets activated and worsen stroke outcome after ischemia/reperfusion (I/R) injury by inducing inflammation and apoptosis.. In this study, tideglusib, a selective irreversible and non-ATP competitive inhibitor of GSK-3b, was explored in cerebral I/R damage using middle cerebral artery occlusion (MCAo) model in rats.. Materials and Methods: MCAo was done for 90 min in male Wistar rats (250-280 g) using doccol suture. Magnetic Resonance Imaging:Article Title: Tideglusib Ameliorates Ischemia/Reperfusion Damage by Inhibiting GSK-3β and Apoptosis in Rat Model of Ischemic Stroke. Article Snippet: rnal of Stroke and Cer Objectives: Glycogen synthase kinase-3b (GSK-3b), a serine/threonine protein kinase, gets activated and worsen stroke outcome after ischemia/reperfusion (I/R) injury by inducing inflammation and apoptosis.. In this study, tideglusib, a selective irreversible and non-ATP competitive inhibitor of GSK-3b, was explored in cerebral I/R damage using middle cerebral artery occlusion (MCAo) model in rats.. Materials and Methods: MCAo was done for 90 min in male Wistar rats (250-280 g) using doccol suture. |